BACKGROUND
Retatrutide, an investigational triple agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors, may be useful for treating obstructive sleep apnea (OSA).
METHODS
In two phase 3, double-blind, randomized, placebo-controlled trials nested within larger basket...
R. Grunstein, V. Somers, A. Azarbarzin et al.· New England Journal of Medic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.